AstraZeneca’s Imfinzi gets EU nod for use in bladder cancer treatment
The approval is supported by findings from the NIAGARA Phase III trial, published in The New England Journal of Medicine.

A leading resource for the Pharmaceutical industry since 2002
The approval is supported by findings from the NIAGARA Phase III trial, published in The New England Journal of Medicine.
Chemspec Europe 2025 returns to Cologne with expanded exhibition space, enhanced digital tools, and a diverse line-up of industry leaders. This premier event will showcase cutting-edge solutions across key sectors,...
Seal the deal
Excipient evolution shaping pharma innovation
Solving the EDDO guidance puzzle
AI-driven delivery